Reagenta Pharmaceuticals Private Limited
About Reagenta Pharmaceuticals Private Limited
Data last updated:
Reagenta Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2019PTC331080. Its GSTIN is 23AAJCR8331B1ZO (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyanka Mishra and Prabhakar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 101 Floor Grd Shanti Nagar Hutments Saltpan Road Antop Hill, Mumbai, Maharashtra, India – 400037.
As per the financials filed for FY 2025, the company reported a revenue of ₹69.17 Lakh, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹56,557 (net margin 0.8%) and EBITDA of ₹2.99 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Company details
Contact details
Reagenta Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 101 Floor Grd Shanti Nagar Hutments Saltpan Road Antop Hill, Mumbai, Maharashtra, India – 400037
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Reagenta Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reagenta Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Reagenta Pharmaceuticals Private Limited, buy the company report.
Financials of Reagenta Pharmaceuticals Private Limited
FY 2025 filings availableReagenta Pharmaceuticals Private Limited reported revenue of ₹69.17 Lakh (up 56% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 56% growth in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56,557 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reagenta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Mishra | Director | 27 Sep 2019 | 7 Years 0 Months | Current |
| Prabhakar Mishra | Director | 27 Sep 2019 | 7 Years 0 Months | Current |
Auditor
Reagenta Pharmaceuticals Private Limited is audited by Arif Jain & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Arif Jain & Associates | FY 2022 | 017628C |
Shareholding
The shareholding of Reagenta Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Reagenta Pharmaceuticals Private Limited, buy the company report.
Legal cases
Reagenta Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Reagenta Pharmaceuticals. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (COMMS) | Filed by the company against M/S Ragenta Pharmaceuticals | Pending |
To see the full case history of Reagenta Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reagenta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reagenta Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAJCR8331B1ZO | Madhya Pradesh | Active | 12 Sep 2020 |
To see the full GST registrations and return filing status of Reagenta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Reagenta Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Prabhakar Mishra was appointed as Director on 27 Sep 2019.
Frequently asked questions
Reagenta Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 September 2019 (7+ years old) and is registered under CIN U51909MH2019PTC331080.
Reagenta Pharmaceuticals has 2 current directors:
- Priyanka Mishra - Director
- Prabhakar Mishra - Director
The latest financial statements of Reagenta Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Reagenta Pharmaceuticals is 23AAJCR8331B1ZO, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Reagenta Pharmaceuticals is U51909MH2019PTC331080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reagenta Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Reagenta Pharmaceuticals was incorporated on 27 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Prabhakar Mishra was appointed as Director on 27 Sep 2019. Priyanka Mishra was appointed as Director on 27 Sep 2019.
The registered office of Reagenta Pharmaceuticals is at House No. 101 Floor Grd Shanti Nagar Hutments Saltpan Road Antop Hill, Mumbai, Maharashtra, India – 400037.
Reagenta Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.